๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hyperlipidemia
Clinical trial register · China

Hyperlipidemia Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 4 Guangzhou 3 Beijing 3 Xi'an 1 Hangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai4 Guangzhou3 Beijing3 Xi'an1 Hangzhou1
All 10 locations
Target enrolment
to

Hyperlipidemia trials in China

16 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia
NCT07799688Hyperlipidemia
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
400
Jinan, Shanghai
2026-09-30
Not yet open
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
NCT07674524Non-Small Cell Lung Cancer (NSCLC), Hyperlipidemia, ALK Gene Mutation, ALK-positive
Sun Yat-sen University
Observational
160
Guangzhou
2026-08-01
Not yet open
Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals
NCT07712042Hyperlipidemia
Mei Gao
Observational
60
Ji'nan
2026-08
Not yet open
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
NCT07722299Hyperlipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 1
120
Guangzhou
2026-07-21
Not yet open
Chronic Kidney Disease and Metabolic Disorders in the Elderly
NCT07494526Chronic Kidney Diease, Diabetes Mellitus, Hypertension, Hyperlipidemia
Chinese PLA General Hospital
Observational
100,000
Beijing
2026-04
Recruiting
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT
NCT07720232Hypertriglyceridemic Acute Pancreatitis, Acute Pancreatitis, Hypertriglyceridemia-induced, Hyperlipidemia
Jianyin Zhou
Phase 4
180
Xiamen
2026-01-18
Recruiting
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
NCT07230730Hyperlipidemia
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 3
900
Hangzhou
2026-01-13
Recruiting
Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia
NCT07662330Obesity & Overweight, Hyperlipidemia
Shanghai 10th People's Hospital
Not applicable
50
Shanghai
2026-01-01
Recruiting
A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia
NCT07229937Hyperlipidemia
Shandong Suncadia Medicine Co., Ltd.
Phase 2
189
Harbin
2025-11-25
Recruiting
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
NCT06615609Post Coronary Artery Bypass Grafting, Hypertension, Diabetes Mellitus, Hyperlipidemia
China National Center for Cardiovascular Diseases
Not applicable
536
รœrรผmqi
2025-09-24
Active, closed
A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
NCT07100418Hyperlipidemia
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
224
Shanghai
2025-08-12
Not yet open
Intervention Study on Digital Health Management
NCT06949306Hypertension, Hyperlipidemia
Shanghai 10th People's Hospital
Not applicable
300
Shanghai
2025-07-01
Recruiting
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
NCT07400549Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia
China National Center for Cardiovascular Diseases
Not applicable
100
Beijing
2025-06-01
Recruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06684106Hyperlipidemia, Ursodeoxycholic Acid, Statin Therapy, Glucose Intolerance
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
128
Xi'an
2024-11-25
By invitation
LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
NCT06876675Non-Small Cell Lung Cancer, Hyperlipidemia
Peking University Third Hospital
Observational
167
Beijing
2024-10-15
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/hyperlipidemia

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies listing the condition Hyperlipidemia.

How many Hyperlipidemia trials are recruiting in China?

8 of the 16 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hyperlipidemia), 16 studies
PhaseStudiesRecruitingShare
Not applicable5431.3%
Observational5131.3%
Phase 23118.8%
Phase 1106.3%
Phase 3116.3%
Phase 4116.3%

Most active sponsors

Lead sponsors with the most studies (Hyperlipidemia)
Lead sponsorStudiesRecruiting
China National Center for Cardiovascular Diseases22
Fujian Shengdi Pharmaceutical Co., Ltd.20
Shanghai 10th People's Hospital21
Beijing Suncadia Pharmaceuticals Co., Ltd11
Chinese PLA General Hospital10
First Affiliated Hospital Xi'an Jiaotong University11
Jianyin Zhou11
Mei Gao10
Peking University Third Hospital10
Shandong Suncadia Medicine Co., Ltd.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.